Literature DB >> 9135696

Mutations of the 5 alpha-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5 alpha-reductase-2 deficiency.

P Canto1, F Vilchis, B Chávez, O Mutchinick, J Imperato-McGinley, G Pérez-Palacios, A Ulloa-Aguirre, J P Méndez.   

Abstract

BACKGROUND AND
OBJECTIVE: Male pseudohermaphroditism due to 5 alpha-reductase deficiency was originally described in 1974. Recently, 5 alpha-reductase Type 2 gene defects have been found generally to be due to point mutations within the 5 exons of the 5 alpha-reductase-2 gene. In this report, we describe the molecular study of patients with 5 alpha-reductase deficiency.
DESIGN: Previously diagnosed patients with 5 alpha-reductase deficiency were sampled in order to perform molecular studies. PATIENTS: Eight 5 alpha-reductase deficient individuals from 6 unrelated families. MEASUREMENTS: Single-strand conformational polymorphism and DNA sequencing were performed after polymerase chain reaction amplification of each of the 5 exons of the gene.
RESULTS: Five different missense mutations were found. In 4 patients a cytosine to guanine substitution was observed at codon 212 in exon 4. Two siblings presented a cytosine to adenine substitution at codon 207 in exon 4. Another patient exhibited a guanine to adenine substitution at codon 34 in exon 1, whilst one individual presented 2 mutations: a guanine to adenine substitution at codon 115 in exon 2 and a guanine to adenine substitution at codon 203 in exon 4 (previously undescribed mutation).
CONCLUSIONS: The presence of the same mutation in 4 patients from 3 families indicates the increased prevalence of this mutation in a particular ethnic group, suggesting a common ancestry for the gene defect in these patients. The existence of hot spots is supported by the mutations in codons 34 and 207 which have also been found in other ethnic groups. Interestingly, the patient who presented 2 different mutations, one of them previously undescribed, was reared as a male and exhibited a more masculine phenotype. Further studies in patients with this and other mutations will be needed to verify genotype-phenotype correlation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135696     DOI: 10.1046/j.1365-2265.1997.800904.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  Practical approach to steroid 5alpha-reductase type 2 deficiency.

Authors:  Chong Kun Cheon
Journal:  Eur J Pediatr       Date:  2010-03-28       Impact factor: 3.183

2.  New mutations, hotspots, and founder effects in Brazilian patients with steroid 5alpha-reductase deficiency type 2.

Authors:  Christine Hackel; Luiz Eduardo Chimello Oliveira; Lucio Fabio Caldas Ferraz; Maria Manuela Oliveira Tonini; Daniela Nunes Silva; Maria Betania Toralles; Eliana Gabas Stuchi-Perez; Gil Guerra-Junior
Journal:  J Mol Med (Berl)       Date:  2005-03-16       Impact factor: 4.599

3.  The IVS1-2A>G mutation in the SRD5A2 gene predominates in Cypriot patients with 5α reductase deficiency.

Authors:  N Skordis; V Neocleous; A Kyriakou; E Efstathiou; A Sertedaki; P Philibert; L A Phylactou; S Lumbroso; C Sultan
Journal:  J Endocrinol Invest       Date:  2010-05-28       Impact factor: 4.256

4.  Novel compound heterozygous mutations in the SRD5A2 gene from 46,XY infants with ambiguous external genitalia.

Authors:  Felipe Vilchis; Evangelina Valdez; Luis Ramos; Rocio García; Rita Gómez; Bertha Chávez
Journal:  J Hum Genet       Date:  2008-03-19       Impact factor: 3.172

5.  Genetic Analysis of 25 Patients with 5α-Reductase Deficiency in Chinese Population.

Authors:  Bing Han; Tong Cheng; Hui Zhu; Jie Yu; Wen-Jiao Zhu; Huai-Dong Song; Haijun Yao; Jie Qiao
Journal:  Biomed Res Int       Date:  2020-06-09       Impact factor: 3.411

6.  46,XY disorder of sexual development resulting from a novel monoallelic mutation (p.Ser31Phe) in the steroid 5α-reductase type-2 (SRD5A2) gene.

Authors:  Bertha Chávez; Luis Ramos; Rita Gómez; Felipe Vilchis
Journal:  Mol Genet Genomic Med       Date:  2014-03-16       Impact factor: 2.183

7.  Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 Deficiency.

Authors:  Nanis S Marzuki; Firman P Idris; Hannie D Kartapradja; Alida R Harahap; Jose R L Batubara
Journal:  Int J Endocrinol       Date:  2019-12-01       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.